Teck: Quebrada Blanca Phase 2 Receives Regulatory Approval

Teck Resources (TSX:TECK.A,TSX:TECK.B,NYSE:TECK) has announced that it has received regulatory approval for its Quebrada Blanca phase 2 project (QB2) in the Tarapacá Region in northern Chile. According to Teck’s release, the regional environmental committee of Tarapacá has voted to approve the project environmental impact assessment. Receipt of the environmental qualification resolution is expected in the […]

Cobalt Blockchain Announces Approval of DRC Cobalt and Copper License, Expects to Commence Minerals Trading

Cobalt Blockchain Inc. (“COBC” or the “Company”) (TSXV:COBC) is pleased to announce that it has received final approval for its application for a cobalt and copper license in the Democratic Republic of the Congo (“DRC”). The federal Ministry of Mines today certified the license application, renewable after two years, based on the Company’s submissions and the provincial […]

Khiron Life Sciences Receives Colombian Government Approval To Sell CBD Wellness Products

Khiron Life Sciences Corp. (TSXV:KHRN) has received a feature on Cosmetics Design highlighting the Colombian Government’s recent sanction that would allow the company to make, sell and export several CBD wellness products. Incremental progress is being made in the Americas towards widespread adoption of “cannabis, hemp and CBD-derived personal care ingredients.” The article also highlights […]

Anavex Life Sciences Receives Approval to Initiate Phase 2 Clinical Trial of ANAVEX2-73 for the Treatment of Parkinson’s Disease Dementia

Anavex Life Sciences (Nasdaq:AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases, today announced that the Company has received approval from the Spanish Agency for Medicinal Products and Medical Devices (AEMPS), to initiate its Phase 2, double-blind, placebo-controlled 14-week trial of the safety and efficacy of ANAVEX®2-73 for […]

Theratechnologies Submits Novel Single-Vial Formulation of EGRIFTA (Tesamorelin for Injection) for FDA Approval

Theratechnologies (TSX:TH) today announced that it has filed a supplemental new drug application (sNDA) with the Food and Drug Administration (FDA) for a single-vial formulation of EGRIFTA. As quoted in the press release: The filing is based on bioequivalence studies which were completed earlier this year. The new single-vial formulation, known as “F4”, is four times […]